• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用阻塞肽纳米颗粒的空间位阻抑制血小板黏附到暴露的内皮下胶原。

Inhibition of platelet adhesion to exposed subendothelial collagen by steric hindrance with blocking peptide nanoparticles.

机构信息

School of Energy and Environmental Engineering, University of Science and Technology Beijing, Beijing 100083, China.

School of Energy and Environmental Engineering, University of Science and Technology Beijing, Beijing 100083, China; Shunde Graduate School of University of Science and Technology Beijing, Shunde, Guangdong Province 528399, China.

出版信息

Colloids Surf B Biointerfaces. 2024 May;237:113866. doi: 10.1016/j.colsurfb.2024.113866. Epub 2024 Mar 20.

DOI:10.1016/j.colsurfb.2024.113866
PMID:38520952
Abstract

The inhibition of platelet adhesion to collagen in exposed vessels represents an innovative approach to the treatment of atherosclerosis and thrombosis. This study aimed to engineer peptide-based nanoparticles that prevent platelet binding to subendothelial collagen by engaging with collagen with high affinity. We examined the interactions between integrin α2/ glycoprotein VI/ von Willebrand factor A3 domain and collagen, as well as between the synthesized peptide nanoparticles and collagen, utilizing molecular dynamics simulations and empirical assays. Our findings indicated that the bond between von Willebrand factor and collagen was more robust. Specifically, the sequences SITTIDV, VDVMQRE, and YLTSEMH in von Willebrand factor were identified as essential for its attachment to collagen. Based on these sequences, three peptide nanoparticles were synthesized (BPa: Capric-GNNQQNYK-SITTIDV, BPb: Capric-GNNQQNYK-VDVMQRE, BPc: Capric-GNNQQNYK-YLTSEMH), each displaying significant affinity towards collagen. Of these, the BPa nanoparticles exhibited the most potent interaction with collagen, leading to a 75% reduction in platelet adhesion.

摘要

抑制暴露血管中的血小板黏附于胶原代表了一种治疗动脉粥样硬化和血栓形成的创新方法。本研究旨在设计基于肽的纳米颗粒,通过与胶原高亲和力结合来防止血小板与内皮下胶原结合。我们利用分子动力学模拟和经验性检测,研究了整合素 α2/糖蛋白 VI/血管性血友病因子 A3 结构域与胶原之间,以及合成肽纳米颗粒与胶原之间的相互作用。我们的研究结果表明,血管性血友病因子与胶原之间的结合更为牢固。具体而言,血管性血友病因子中序列 SITTIDV、VDVMQRE 和 YLTSEMH 被鉴定为其与胶原附着的必需序列。基于这些序列,我们合成了三种肽纳米颗粒(BPa:Capric-GNNQQNYK-SITTIDV、BPb:Capric-GNNQQNYK-VDVMQRE、BPc:Capric-GNNQQNYK-YLTSEMH),它们均显示出对胶原的显著亲和力。其中,BPa 纳米颗粒与胶原的相互作用最强,导致血小板黏附减少 75%。

相似文献

1
Inhibition of platelet adhesion to exposed subendothelial collagen by steric hindrance with blocking peptide nanoparticles.利用阻塞肽纳米颗粒的空间位阻抑制血小板黏附到暴露的内皮下胶原。
Colloids Surf B Biointerfaces. 2024 May;237:113866. doi: 10.1016/j.colsurfb.2024.113866. Epub 2024 Mar 20.
2
Simple collagen-like peptides support platelet adhesion under static but not under flow conditions: interaction via alpha2 beta1 and von Willebrand factor with specific sequences in native collagen is a requirement to resist shear forces.简单的类胶原蛋白肽在静态条件下可支持血小板黏附,但在流动条件下则不然:通过α2β1和血管性血友病因子与天然胶原蛋白中的特定序列相互作用是抵抗剪切力的必要条件。
Blood. 1998 May 15;91(10):3808-16.
3
The leech product saratin is a potent inhibitor of platelet integrin alpha2beta1 and von Willebrand factor binding to collagen.水蛭素产品沙瑞亭是血小板整合素α2β1和血管性血友病因子与胶原蛋白结合的强效抑制剂。
FEBS J. 2007 Mar;274(6):1481-91. doi: 10.1111/j.1742-4658.2007.05689.x.
4
Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood.在流动的血液中使用受体特异性胶原蛋白模拟肽底物定义血小板胶原受体之间的协同作用。
Blood. 2010 Jun 17;115(24):5069-79. doi: 10.1182/blood-2010-01-260778. Epub 2010 Mar 29.
5
Identification of domains responsible for von Willebrand factor type VI collagen interaction mediating platelet adhesion under high flow.鉴定介导高剪切力下血小板黏附的血管性血友病因子与VI型胶原蛋白相互作用的结构域。
J Biol Chem. 1999 Jan 29;274(5):3033-41. doi: 10.1074/jbc.274.5.3033.
6
Collagen-mimetic peptides mediate flow-dependent thrombus formation by high- or low-affinity binding of integrin alpha2beta1 and glycoprotein VI.胶原蛋白模拟肽通过整合素α2β1和糖蛋白VI的高亲和力或低亲和力结合介导血流依赖性血栓形成。
J Thromb Haemost. 2008 Dec;6(12):2132-42. doi: 10.1111/j.1538-7836.2008.03167.x. Epub 2008 Sep 29.
7
Adhesive domains in the collagen III fragment alpha1(III)CB4 that support alpha2beta1- and von Willebrand factor-mediated platelet adhesion under flow conditions.胶原蛋白III片段α1(III)CB4中的黏附结构域,在流动条件下支持α2β1和血管性血友病因子介导的血小板黏附。
Thromb Haemost. 1999 Sep;82(3):1137-44.
8
A single high-affinity binding site for von Willebrand factor in collagen III, identified using synthetic triple-helical peptides.利用合成三螺旋肽鉴定出胶原蛋白III中血管性血友病因子的单一高亲和力结合位点。
Blood. 2006 Dec 1;108(12):3753-6. doi: 10.1182/blood-2006-03-011965. Epub 2006 Aug 15.
9
Are integrin alpha(2)beta(1), glycoprotein Ib and vWf levels correlated with their contributions to platelet adhesion on collagen under high-shear flow?整合素 α(2)β(1)、糖蛋白 Ib 和 vWf 水平与其在高剪切流条件下对胶原表面血小板黏附的贡献是否相关?
Platelets. 2010;21(2):101-11. doi: 10.3109/09537100903497549.
10
Coarse-grained simulations of von Willebrand factor adsorption to collagen with consequent platelet recruitment.粗粒化模拟 von Willebrand 因子吸附到胶原蛋白上,从而导致血小板的募集。
Int J Numer Method Biomed Eng. 2023 Nov;39(11):e3747. doi: 10.1002/cnm.3747. Epub 2023 Jun 27.

引用本文的文献

1
Targeted and Biomimetic Nanoparticles for Atherosclerosis Therapy: A Review of Emerging Strategies.用于动脉粥样硬化治疗的靶向及仿生纳米颗粒:新兴策略综述
Biomedicines. 2025 Jul 14;13(7):1720. doi: 10.3390/biomedicines13071720.
2
Functional characterization of a common XIa inhibitory Kunitz-domain Shp4 from nine schistosoma secreted proteins with diverse C-terminal fragments.来自九种具有不同C端片段的血吸虫分泌蛋白的常见XIa抑制性Kunitz结构域Shp4的功能表征。
PLoS Negl Trop Dis. 2025 Jul 8;19(7):e0013282. doi: 10.1371/journal.pntd.0013282. eCollection 2025 Jul.
3
Platelets and diseases: signal transduction and advances in targeted therapy.
血小板与疾病:信号转导及靶向治疗进展
Signal Transduct Target Ther. 2025 May 16;10(1):159. doi: 10.1038/s41392-025-02198-8.